Dr. Haught is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
930 Franklin St Se
Huntsville, AL 35801Phone+1 256-539-4080Fax+1 256-539-4099
Education & Training
- University of FloridaFellowship, Cardiovascular Disease, 1992 - 1995
- University of FloridaResidency, Internal Medicine, 1989 - 1992
- Ohio State University College of MedicineClass of 1989
Certifications & Licensure
- AL State Medical License 1998 - 2024
- TN State Medical License 2003 - 2021
- FL State Medical License 1990 - 2000
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 110 citationsShort-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.Marvin A. Konstam, Michael S. Kiernan, Arthur Chandler, Ravi Dhingra, Freny Vaghaiwalla Mody
Journal of the American College of Cardiology. 2017-03-21 - 69 citationsEfficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot StudySteven R. Goldsmith, Uri Elkayam, W. Herbert Haught, Abhijit Barve, Weizhong He
Journal of Cardiac Failure. 2008-10-01 - 147 citationsAcute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multi...James E. Udelson, Cesare Orlandi, John Ouyang, Holly B. Krasa, Christopher Zimmer
Journal of the American College of Cardiology. 2007-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: